Avita Medical Overview

  • Year Founded
  • 1993

Year Founded

  • Status
  • Public

  • Employees
  • 226

Employees

  • Stock Symbol
  • RCEL

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $15.62
  • (As of Friday Closing)

Avita Medical General Information

Description

Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.

Contact Information

Formerly Known As
Clinical Cell Culture, Avita Therapeutics
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 28159 Avenue Stanford
  • Suite 220
  • Valencia, CA 91355
  • United States
+1 (833)
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Stock Exchange
NAS
Corporate Office
  • 28159 Avenue Stanford
  • Suite 220
  • Valencia, CA 91355
  • United States
+1 (833)

Avita Medical Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Avita Medical Stock Performance

As of 20-Nov-2026, Avita Medical’s stock price is $15.62. Its current market cap is $495M with 31.7M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$15.62 $15.99 $3.22 - $18.43 $495M 31.7M 416K -$1.18

Avita Medical Financials Summary

As of 30-Sep-2026, Avita Medical has a trailing 12-month revenue of $84.7M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 400,118 126,661 337,031 293,816
Revenue 84,682 71,610 64,251 50,143
EBITDA (28,540) (41,246) (55,425) (33,767)
Net Income (36,117) (48,587) (61,845) (35,381)
Total Assets 46,794 56,392 79,711 111,640
Total Debt 47,134 46,048 45,985 42,409
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Avita Medical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Avita Medical‘s full profile, request access.

Request a free trial

Avita Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-
Therapeutic Devices
Valencia, CA
226 As of 2025

Alachua, FL
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Avita Medical Competitors (1)

One of Avita Medical’s competitors is NovaBone, a Private Equity-Backed company based in Alachua, FL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NovaBone Private Equity-Backed Alachua, FL
You’re viewing 1 of 1 competitors. Get the full list »

Avita Medical Patents

Avita Medical Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-6479757-B2 System and method for performing tissue processing and preparation of its cell suspension Active 14-Mar-2013
JP-2016512689-A System and method for performing tissue treatment and cell suspension preparation thereof Active 14-Mar-2013
CA-2906088-A1 Systems and methods for tissue processing and preparation of cell suspension therefrom Pending 14-Mar-2013
WO-2014153072-A1 Systems and methods for tissue processing and preparation of cell suspension therefrom Inactive 14-Mar-2013
US-20150079153-A1 Cell suspension and use thereof Inactive 22-Mar-2012 A61L15/36
To view Avita Medical’s complete patent history, request access »

Avita Medical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Avita Medical Investments (1)

Avita Medical’s most recent deal was a Corporate Asset Purchase with Manufacturing plant (Ventura). The deal was made on 01-Jul-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Manufacturing plant (Ventura) 01-Jul-2018 Corporate Asset Purchase Buildings and Property
To view Avita Medical’s complete investments history, request access »

Avita Medical ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

29.78 | Med Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,593

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Devices

Subindustry

of 209

Rank

Percentile

To view Avita Medical’s complete esg history, request access »

Avita Medical FAQs

  • When was Avita Medical founded?

    Avita Medical was founded in 1993.

  • Where is Avita Medical headquartered?

    Avita Medical is headquartered in Valencia, CA.

  • What is the size of Avita Medical?

    Avita Medical has 226 total employees.

  • What industry is Avita Medical in?

    Avita Medical’s primary industry is Therapeutic Devices.

  • Is Avita Medical a private or public company?

    Avita Medical is a Public company.

  • What is Avita Medical’s stock symbol?

    The ticker symbol for Avita Medical is RCEL.

  • What is the current stock price of Avita Medical?

    As of 20-Nov-2026 the stock price of Avita Medical is $15.62.

  • What is the current market cap of Avita Medical?

    The current market capitalization of Avita Medical is $495M.

  • What is Avita Medical’s current revenue?

    The trailing twelve month revenue for Avita Medical is $84.7M.

  • Who are Avita Medical’s competitors?

    NovaBone is a competitor of Avita Medical.

  • What is Avita Medical’s annual earnings per share (EPS)?

    Avita Medical’s EPS for 12 months was -$1.18.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process